Try the modernized beta website. Learn more about the modernization effort.
Working… Menu

A Study to Evaluate XEN1101 as Adjunctive Therapy in Focal Epilepsy

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT03796962
Recruitment Status : Active, not recruiting
First Posted : January 8, 2019
Last Update Posted : November 1, 2021
NCGS, Inc.
Information provided by (Responsible Party):
Xenon Pharmaceuticals Inc.

No Study Results Posted on for this Study
Recruitment Status : Active, not recruiting
Actual Primary Completion Date : September 2, 2021
Estimated Study Completion Date : October 2024